Vitamin E Supplementation in Burned Patients
Status and phase
Conditions
Treatments
Details and patient eligibility
About
A dietary antioxidant, alpha-tocopherol, will be used to potentially attenuate Vitamin E short- and long-term losses in plasma and adipose, reverse the oxidative stress of burn injury and, in the process, decrease the secondary consequences of burn injury, including lung injury and impaired wound healing. This may improve the quality of life of the burn patient by preventing pathophysiology that may result from oxidative stress and may reduce hospital stay. Our research will lay the foundation for the future development of effective, safe, and economic therapeutic interventions to treat burn injury-associated metabolic abnormalities. Also, it will provide the basis for the development of supplemental regulations and pharmacotherapy to treat burn patients with vitamin E. The risks are very reasonable in relation to the anticipated benefits to our subjects because a) vitamin E is a simple vitamin that is abundant and approved for clinical use, and b) the subjects will be monitored consistently for the minimal increased tendency to bleed.
Full description
Please see above.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Age: 16 - 85 years
- ≥40% total body surface area burn
Exclusion criteria
- Septic shock
- Bleeding disorders
- Diabetes, or on diabetes medications or anti-lipidemic agents
- Arthritis
- Known kidney/renal disease, endocrine disease, cancer, heart disease, osteoporosis, liver disease
- Congestive heart failure
- Positive hepatitis or HIV screens
- Pregnancy (women)
Trial design
Primary purpose
Allocation
Interventional model
Masking
31 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal